These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 7002122)

  • 41. [Calcium antagonists and adenosine derivatives in the treatment of patients with chronic ischemic heart disease].
    Kuz'ko NV
    Vrach Delo; 1988 Oct; (10):16-9. PubMed ID: 3218185
    [No Abstract]   [Full Text] [Related]  

  • 42. [Cycloergometric evaluation of propatylnitrate in chronic coronary insufficiency].
    Armaganijan D; Batlouni M; Ghorayeb N; Dioguardi GS; Ogawa C
    Arq Bras Cardiol; 1980 Jan; 34(1):73-7. PubMed ID: 6996650
    [No Abstract]   [Full Text] [Related]  

  • 43. [Calmodulin antagonists in general practice. Evaluation of the side-effect spectrum].
    Kartnik G
    Fortschr Med Suppl; 1986; 3():18-9. PubMed ID: 2870964
    [No Abstract]   [Full Text] [Related]  

  • 44. [Action of nifedipine on the response to exertion and on peripheral tissue oxygenation. Comparative study of healthy individuals and coronary insufficiency patients].
    Botas L; Freitas JP; Barroca JP; Proenca C; Pereira JM; Martins e Silva JA
    Rev Esp Cardiol; 1982; 35(5 Suppl 2):II75-81. PubMed ID: 6763270
    [No Abstract]   [Full Text] [Related]  

  • 45. [Calcium antagonists (finoptin and senzit) in the treatment of cerebrovascular disorders].
    Burtsev EM; Savkov VS
    Klin Med (Mosk); 1989 Sep; 67(9):51-4. PubMed ID: 2586041
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [On the treatment of coronary insufficiency].
    Pezzana A; Maltoni N
    Minerva Cardioangiol; 1967 Jan; 15(1):50-7. PubMed ID: 5597264
    [No Abstract]   [Full Text] [Related]  

  • 47. [Effect of hexoprenaline on respiratory and heart functions in chronic obstructive lung disease].
    Cholevas M; Economidis D; Lefkos N; Sakamadis G; Concouris L
    Wien Med Wochenschr Suppl; 1978; 50():1-7. PubMed ID: 280024
    [No Abstract]   [Full Text] [Related]  

  • 48. [Effect of fendiline-hydrochloride (Sensit) in a cross-over-test. Comparative study].
    Kandziora J
    MMW Munch Med Wochenschr; 1978 Jul; 120(27):937-7. PubMed ID: 351382
    [No Abstract]   [Full Text] [Related]  

  • 49. [Results of clinical studies of beta stimulating agents in the treatment of chronic heart disease].
    Metelutsa VI; Chazova LV; Grigor'iants RA; Krol VA; Trubetskoĭ AV
    Ter Arkh; 1977; 49(4):44-8. PubMed ID: 17171
    [No Abstract]   [Full Text] [Related]  

  • 50. [The role of the sympathomimetic activity of beta-adrenergic blockaders in the treatment of patients with chronic ischemic heart disease].
    Ol'binskaia LI; Bragina GI
    Ter Arkh; 1983; 55(9):35-40. PubMed ID: 6138864
    [No Abstract]   [Full Text] [Related]  

  • 51. [Radioelectrocardiographic indices during physical effort in persons with chronic coronary insufficiency].
    Cherevatov BG
    Sov Med; 1971 Apr; 34(4):94-9. PubMed ID: 5143764
    [No Abstract]   [Full Text] [Related]  

  • 52. [Drug-support of active therapy for rehabilitation in coronary insufficiency].
    Schleusing G
    Z Gesamte Inn Med; 1970 Aug; 25(15):680-5. PubMed ID: 5005761
    [No Abstract]   [Full Text] [Related]  

  • 53. [Evaluation of the effects of slow-release metoprolol in chronic coronary insufficiency].
    Armaganijan D; Batlouni M
    Arq Bras Cardiol; 1983 Aug; 41(2):157-9. PubMed ID: 6372751
    [No Abstract]   [Full Text] [Related]  

  • 54. Mechanical activity of the ischaemic myocardium as affected by verapamil and fendiline.
    Hála O; Papp JG; Szekeres L
    Acta Physiol Hung; 1990; 75 Suppl():139-40. PubMed ID: 2371843
    [No Abstract]   [Full Text] [Related]  

  • 55. [Indices of tolerance to exertion in chronic coronary insufficiency].
    Terno VS; Kucheriavyĭ PG; Taktuk EE
    Vrach Delo; 1980 Nov; (11):39-42. PubMed ID: 7467258
    [No Abstract]   [Full Text] [Related]  

  • 56. [Our experiences with Nitrolingual Retard in chronic coronary insufficiency].
    Szirmai E; Szántay J
    Acta Med Okayama (1952); 1970 Aug; 24(4):489-91. PubMed ID: 4254203
    [No Abstract]   [Full Text] [Related]  

  • 57. [Clinical experience with the new coronary therapeutic agent Sensit].
    Messerich J
    Med Welt; 1975 Nov; 26(47):2160-2. PubMed ID: 1105057
    [No Abstract]   [Full Text] [Related]  

  • 58. [Clinical observations of using nifedipine in coronary disease].
    Goch JH; Adamska-Dyniewska H; Tkaczewski W; Brzozowski R; Dziekański S; Rosiek S; Kruszyński G
    Kardiol Pol; 1987; 30 Suppl():54-60. PubMed ID: 3331400
    [No Abstract]   [Full Text] [Related]  

  • 59. [Recent contribution to the study on the effects of hexobendine in the treatment of coronary insufficiency].
    Diene G; Nigro P; Cottini E; Andreozzi GM; Mossuti E; Sorrentino F
    Boll Soc Ital Cardiol; 1973; 18(12):1213-21. PubMed ID: 4619973
    [No Abstract]   [Full Text] [Related]  

  • 60. [On the effect of the acute administration of propranolol on the electrocardiogram during exercise in chronic coronary disease].
    Lixi M; Raffo M; Porrazzo G; Camoglio E; Cuozzo G; Cherchi A
    Boll Soc Ital Cardiol; 1966; 11(4):1523-9. PubMed ID: 5992068
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.